EP2398902
Aðferðir og samsetningar til greiningar og meðferðar á krabbameini
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
19.2.2010EP published:
4.10.2023EP application number:
10705304.3
EP translation filed:
27.11.2023Grant published:
15.12.2023EPO information:
European Patent Register
Max expiry date:
18.2.2030Expiry date:
18.2.2026Next due date:
28.2.2026
Title in English:
METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF CANCERLanguage of the patent:
English
Timeline
Today
19.2.2010EP application
4.10.2023EP Publication
27.11.2023Translation submitted
15.12.2023Registration published
18.2.2026Expires
Owner
Name:
Astellas Pharma Inc.Address:
5-1, Nihonbashi-Honcho 2-Chome, Chuo-ku Tokyo 103-8411, JP
Name:
TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige GmbHAddress:
Freiligrathstrasse 12, 55131 Mainz, DE
Inventor
Name:
SAHIN, UgurAddress:
55116 Mainz, DE
Name:
TÜRECI, ÖzlemAddress:
55116 Mainz, DE
Name:
KOSLOWSKI, MichaelAddress:
85764 Oberschleissheim, DE
Name:
HELFTENBEIN, GerdAddress:
35329 Gemünden, DE
Name:
KORDEN, WalterAddress:
65203 Wiesbaden, DE
Name:
WÖLL, StefanAddress:
55299 Nackenheim, DE
Name:
OPREA, Gabriela-ElenaAddress:
55128 Mainz, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
09002452Date:
20.2.2009Country:
EP
Number:
09010164Date:
6.8.2009Country:
EP
Number:
09014135Date:
11.11.2009Country:
EP
Number:
154167 PDate:
20.2.2009Country:
US
Number:
231843 PDate:
6.8.2009Country:
US
Number:
260135 PDate:
11.11.2009Country:
US
Classification
Categories:
A61P 35/00, A61P 35/04, A61P 37/04, C12N 15/113, A61K 31/7088
Annual fees
Number
Paid
Expires
Payer
Number: 15
Paid: 6.2.2024
Expires: 18.2.2025
Payer: Árnason Faktor ehf.
Number: 16
Paid: 11.2.2025
Expires: 18.2.2026
Payer: Árnason Faktor ehf.